|
Valoración de DCF de Adex Therapeutics Ltd (ADXN)
CH | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Addex Therapeutics Ltd (ADXN) Bundle
¡Descubra el verdadero potencial de Addex Therapeutics Ltd (ADXN) con nuestra calculadora DCF avanzada! Ajuste los supuestos cruciales, explore varios escenarios y evalúe cómo los diferentes cambios afectan la valoración de Adex Therapeutics Ltd (ADXN), todo dentro de una plantilla de Excel fácil de usar.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.1 | 4.0 | 3.2 | 1.6 | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.3 |
| Revenue Growth, % | 0 | 30.77 | -19.28 | -51.22 | 13.39 | -6.59 | -6.59 | -6.59 | -6.59 | -6.59 |
| EBITDA | -15.9 | -13.8 | -16.6 | -22.4 | -11.3 | -1.7 | -1.6 | -1.5 | -1.4 | -1.3 |
| EBITDA, % | -518.25 | -343.51 | -512.34 | -1422.11 | -634.16 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .4 | .4 | .4 | .4 | .3 | .3 | .2 | .2 | .2 | .2 |
| Depreciation, % | 12.08 | 10.48 | 11.92 | 22.72 | 18.97 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 |
| EBIT | -16.2 | -14.2 | -16.9 | -22.8 | -11.7 | -1.7 | -1.6 | -1.5 | -1.4 | -1.3 |
| EBIT, % | -530.33 | -353.99 | -524.26 | -1444.83 | -653.13 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 35.0 | 20.8 | 22.7 | 7.7 | 4.3 | 1.7 | 1.6 | 1.5 | 1.4 | 1.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .1 | .4 | .7 | .2 | .2 | .2 | .2 | .2 | .2 |
| Account Receivables, % | 4.27 | 1.89 | 11.12 | 42.06 | 9.38 | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 |
| Inventories | .0 | .2 | .0 | -966.2 | .0 | -.3 | -.3 | -.3 | -.3 | -.2 |
| Inventories, % | -0.50557 | 4.51 | 0.000034289931 | -61275.4 | 0 | -19.2 | -19.2 | -19.2 | -19.2 | -19.2 |
| Accounts Payable | 2.5 | 1.1 | 2.0 | 1.4 | 1.1 | 1.1 | 1.0 | .9 | .9 | .8 |
| Accounts Payable, % | 80.21 | 27.22 | 61.29 | 89.74 | 61.03 | 63.9 | 63.9 | 63.9 | 63.9 | 63.9 |
| Capital Expenditure | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -1.03 | -1.64 | -1.08 | -0.04084537 | -0.42419 | -0.84429 | -0.84429 | -0.84429 | -0.84429 | -0.84429 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -16.2 | -14.2 | -16.9 | -22.8 | -11.7 | -1.7 | -1.6 | -1.5 | -1.4 | -1.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -13.6 | -15.3 | -15.8 | 942.9 | -977.4 | -1.2 | -1.4 | -1.3 | -1.2 | -1.2 |
| WACC, % | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 | 13.29 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1 | |||||||||
| Terminal Value | -10 | |||||||||
| Present Terminal Value | -6 | |||||||||
| Enterprise Value | -10 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -6 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | -0.08 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios for Addex Therapeutics Ltd (ADXN).
- Real-World Data: Addex Therapeutics’ financial data pre-filled to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive Data: Addex Therapeutics Ltd's historical financial statements and pre-filled forecasts.
- Customizable Variables: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
- Real-Time Insights: Instantly view the intrinsic value of Addex Therapeutics Ltd (ADXN) as it recalculates.
- Intuitive Visualizations: Dashboard charts present valuation results and essential metrics clearly.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Addex Therapeutics data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Addex Therapeutics' intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Addex Therapeutics Ltd (ADXN)?
- Accurate Data: Utilize real Addex Therapeutics financials for trustworthy valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-built calculations streamline the process, eliminating the need to start from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Simple layout and guided instructions ensure accessibility for all users.
Who Should Use This Product?
- Pharmaceutical Students: Understand drug development processes and apply them using real market data.
- Researchers: Integrate advanced models into studies or academic papers related to therapeutics.
- Investors: Evaluate your investment strategies and assess valuation scenarios for Addex Therapeutics Ltd (ADXN).
- Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
- Healthcare Entrepreneurs: Learn how large biotech firms like Addex Therapeutics Ltd (ADXN) are evaluated in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Addex Therapeutics Ltd (ADXN).
- Real-World Data: Addex Therapeutics' historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for deeper insights into Addex Therapeutics Ltd (ADXN).
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Addex Therapeutics Ltd (ADXN).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results relevant to Addex Therapeutics Ltd (ADXN).